Delivery Order SPE2DE24D0013-SPE2D626F9997
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $6,800 delivery order (4569923616) by the Defense Logistics Agency Medical Supply Chain on November 4, 2025, with an ultimate completion date of November 12, 2025. The contract is for XPCOV2/FLU/RSV-10 diagnostic products—molecular testing reagents and cartridges for detecting COVID-19, influenza, and respiratory syncytial virus on the GeneXpert diagnostic platform. This is a firm fixed-price delivery order with no set-aside...
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 on September 10, 2025, by the Medical Supply Chain, a defense-focused federal agency. This delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, is associated with Cepheid's larger Indefinite Delivery Vehicle (IDV) contract with the Veterans Affairs Veterans Integrated Service Network 21, valued at $2.5...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a $68,000 firm fixed-price delivery order (Contract No. 4569923609, XPCOV2/FLU/RSV-10) by the Defense Logistics Agency Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 13, 2025. The delivery order, which carries no set-aside designation, is for diagnostic reagents and test kits related to COVID-19, influenza, and respiratory syncytial virus (RSV)...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a firm fixed-price delivery order valued at $8,603.68 by the Defense Logistics Agency Medical Supply Chain on October 23, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, calls for diagnostic reagents and test kits for the GeneXpert platform, specifically for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Work will be performed in Sunnyvale, California,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $5,236 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on October 29, 2025, with an ultimate completion date of November 13, 2025. The contract, designated as XPCOV2/FLU/RSV-10, is for molecular diagnostic testing supplies and reagents, likely including test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. No...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $8,160 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated as XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus. The award carries no set-aside designation and represents a continuation of...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $13,179.30 firm fixed-price delivery order by the Medical Supply Chain (a Defense agency) on May 2, 2025, with completion scheduled for May 9, 2025. The delivery order, designated 4568136320 ! XPCOV2/FLU/RSV-10, is for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing solutions and carries no set-aside designation. The work will be performed in Sunnyvale,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,080.00 by the Defense Department's Medical Supply Chain on August 12, 2025. This firm fixed-price contract, designated as 4569079038 for XPCOV2/FLU/RSV-10, is scheduled for ultimate completion by August 19, 2025, with performance taking place in Sunnyvale, California. The contract carries no set-aside designation and represents a delivery order likely drawn from...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F9997Delivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $4,320 on November 5, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, designated 4569923600 XPCOV2/FLU/RSV-10, is scheduled for completion by November 13, 2025, and represents procurement of diagnostic testing supplies related to COVID-19, influenza, and respiratory syncytial virus detection. The contract carries no set-aside designation, reflecting Cepheid's competitive position as an established federal supplier of molecular diagnostic solutions. Performance will occur at Cepheid's facility in Sunnyvale, California. This delivery order is consistent with Cepheid's extensive portfolio of federal contracts supporting infectious disease diagnostics across the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and other federal healthcare agencies. Cepheid specializes in advanced molecular diagnostic systems, particularly its GeneXpert platform, which enables rapid detection of respiratory pathogens and other infectious diseases. The company maintains substantial indefinite delivery contracts with the VA, including a $32.8 million agreement with VISN 6 and a $6.7 million contract with VISN 17, both of which generate ongoing delivery orders for diagnostic reagents and test kits through 2030, positioning Cepheid as a core supplier of molecular diagnostic capabilities across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 11/5/25 |